Skip to search formSkip to main contentSkip to account menu

VIPR1 gene

Known as: RDC1, VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1, HVR1 
This gene is involved in the regulation of intestinal cell processes that are affected by vasoactive intestinal peptides.
National Institutes of Health

Related topics

Related topics

12 relations
Cell ProliferationDigestionG Protein-Coupled Receptor SignalingImmune response

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
2008
2008
PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications.
Megakaryocytes and platelets express the Gs-coupled VPAC1 receptor, for which the pituitary adenylyl cyclase-activating peptide… 
2006
2006
VIP provides cellular protection through a specific splice variant of the PACAP receptor: A new neuroprotection target
2004
2004
Duplicated receptors for VIP and PACAP (VPAC1R and PAC1R) in a teleost fish, Fugu rubripes.
Two principal groups of receptors orthologous with human PAC1R and VPAC1R and were identified and characterised at the genomic… 
2003
2003
Pituitary adenylate cyclase‐activating polypeptide inhibits cutaneous immune function
Epidermal nerves are closely associated with Langerhans cells (LC) and may be able to release factors, such as calcitonin gene… 
Highly Cited
2002
Highly Cited
2002
A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.
Pituitary adenylate cyclase-activating peptide (PACAP) and vasoactive intestinal peptide (VIP) activate two shared receptors… 
2000
2000
VIP and PACAP Inhibit Activation Induced Apoptosis in T Lymphocytes
Abstract: Apoptosis in T and B lymphocytes is a major element controlling the immune response. Activation induced cell death… 
2000
2000
Differential Activation of Phospholipase D by VPAC and PAC1 Receptors
Abstract: To investigate the phospholipase D (PLD) responses of the VIP/PACAP receptors, VPAC1 and VPAC2, and the PACAP‐specific… 
1999
1999
T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the…
Hypervariable region-1 (HVR1) from the hepatitis C virus (HCV) envelope protein is thought to be a target for neutralizing Abs… 
1998
1998
Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus–infected patient sera: Relation to viral loads and response to interferon
To clarify the nature of serum anti‐hypervariable region 1 (HVR1) antibodies in patients infected with hepatitis C virus (HCV… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)